USPTO trademark

MAZTEMPRI

AllowedUSPTOWord markClass 5

"MAZTEMPRI" is a word mark owned by Eli Lilly and Company, filed at the USPTO on May 20, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

Official USPTO record
MAZTEMPRI trademark as filed
As filed with the USPTO
Status
Allowed
Since October 15, 2026
Filed
May 20, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99193404
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns MAZTEMPRI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services MAZTEMPRI is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 2 granted
  3. Sou extension 2 filed
  4. Sou teas extension received
  5. Notice of approval of extension request e-mailed
  6. Sou extension 1 granted
  7. Case assigned to intent to use paralegal
  8. Teas change of correspondence received
  9. Attorney/dom.rep.revoked and/or appointed
  10. Teas revoke/app/change addr of atty/dom rep received

10 earlier steps on the official record.

FAQ

About MAZTEMPRI

Who owns the trademark "MAZTEMPRI"?

The USPTO trademark "MAZTEMPRI" (application 99193404) is owned by Eli Lilly and Company.

What is the status of "MAZTEMPRI"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MAZTEMPRI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2aca-ed51-7728-a2f5-2a552401a425
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2aca-ed51-7728-a2f5-2a552401a425",
  "object": "trademark",
  "mark_text": "MAZTEMPRI",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99193404",
  "filing_date": "2025-05-20",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Eli Lilly and Company",
      "entity_id": "ent_019eb749-c2e4-7669-8d85-00996fda299e"
    }
  ]
}